MYCOPHYTO, a pioneering French biostimulant company, successfully raised €16 million in Series A funding to enhance its production capabilities and expand internationally.

Target Company Overview

Founded in 2017, MYCOPHYTO is an innovative French company that specializes in biostimulants and soil regeneration. It aims to assist farmers in their agro-ecological transition by offering cutting-edge solutions inspired by nature. Utilizing a unique process, MYCOPHYTO produces mycorrhizal fungi that enhance crop growth through a symbiotic relationship with plant roots, allowing for improved access to nutrients and water, even in impoverished soils. The company has established a protected biobank and a strong R&D focus to bolster its commercial traction both in France and internationally.

Recently, MYCOPHYTO announced the successful completion of a €16 million Series A funding round aimed at accelerating its expansion and boosting its international growth ambitions. With this funding, MYCOPHYTO plans to significantly increase its production capacity by establishing its first factory, which will employ sustainable technologies backed by state support. The funding round attracted investments from key players, including Innovacom, BNP Paribas, and the Deep Tech 2030 fund, alongside participation from existing stakeholders, including RSI and Crédit Agricole.

Industry Overview in France

The biostimulant industry in France is rapidly evolving, supported by increasing awareness of sustainable agricultural practices and the critical role climate change plays in modern farming. In 2025, droughts alone accounted for over €10 billion in immediate economic losses in the agricul